<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2018-10-18-21</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-3016</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Факторы пятилетнего прогноза у больных, перенесших острый коронарный синдром</article-title><trans-title-group xml:lang="en"><trans-title>The influence of factors on five-year outcomes after acute coronary syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4832-3197</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ложкина</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Lozhkina</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ложкина Наталья Геннадьевна — доктор медицинских наук, профессор кафедры факультетской терапии НГМУ, кардиолог, научный руководитель Регионального сосудистого центра №1 на базе городской клинической больницы №1 г. Новосибирска.</p></bio><email xlink:type="simple">lozhkina.n@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1610-4069</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хасанова</surname><given-names>М. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Khasanova</surname><given-names>M. Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хасанова Мадина Хусейновна — ассистент кафедры факультетской терапии НГМУ, кардиолог.</p></bio><email xlink:type="simple">madina092014@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1687-4100</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Толмачева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tolmacheva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Толмачева Анастасия Александровна — аспирант кафедры факультетской терапии НГМУ, кардиолог.</p></bio><email xlink:type="simple">tolmacheva_nastena@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0927-5962</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Найдена</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Najdena</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Найдена Екатерина Александровна. — аспирант кафедры факультетской терапии НГМУ, кардиолог.</p></bio><email xlink:type="simple">ekaterina.naydena@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3684-5526</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стафеева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Stafeeva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стафеева Елена Александровна — аспирант кафедры факультетской терапии НГМУ, кардиолог.</p></bio><email xlink:type="simple">alyona.glebchenko@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7128-7887</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козик</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozik</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козик Валентина Александровна — аспирант кафедры факультетской терапии НГМУ, кардиолог.</p></bio><email xlink:type="simple">valiyta90@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9987-8574</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барбарич</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Barbarich</surname><given-names>V. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барбарич Владимир Борисович — руководитель регионального сосудистого центра ГБУЗ НСО “ГКБ № 1”, заведующий отделением неотложной кардиологии в составе регионального сосудистого центра ГБУЗ НСО “ГКБ № 1”, соискатель кафедры факультетской терапии НГМУ, кардиолог.</p></bio><email xlink:type="simple">vl.barbarich.2018@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2998-2322</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куимов</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuimov</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куимов Андрей Дмитриевич — доктор медицинских наук, профессор, заведующий кафедрой факультетской терапии НГМУ, кардиолог.</p></bio><email xlink:type="simple">terapia@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7165-4496</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Maksimov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максимов Владимир Николаевич — доктор медицинских наук, профессор, заведующий лабораторией молекулярно-генетических исследований терапевтических заболеваний.</p><p> </p><p> </p></bio><bio xml:lang="en"><p>Novosibirsk.</p></bio><email xlink:type="simple">medik11@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9425-413X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воевода</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Voevoda</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воевода Михаил Иванович — академик РАН, доктор медицинских наук, профессор, директор НИИ терапии и профилактической медицины - филиала  Института цитологии и генетики СО РАН.</p></bio><bio xml:lang="en"><p>Novosibirsk.</p></bio><email xlink:type="simple">mvoevoda@ya.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Новосибирский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НИИ терапии и профилактической медицины — филиал Института цитологии и генетики СО РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>SRI of Therapy and Prevention Medicine — branch of FSBSI Federal Research Center Institute of Cytology and Genetics of SD RAS</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>23</day><month>10</month><year>2018</year></pub-date><volume>0</volume><issue>10</issue><fpage>18</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ложкина Н.Г., Хасанова М.Х., Толмачева А.А., Найдена Е.А., Стафеева Е.А., Козик В.А., Барбарич В.Б., Куимов А.Д., Максимов В.Н., Воевода М.И., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Ложкина Н.Г., Хасанова М.Х., Толмачева А.А., Найдена Е.А., Стафеева Е.А., Козик В.А., Барбарич В.Б., Куимов А.Д., Максимов В.Н., Воевода М.И.</copyright-holder><copyright-holder xml:lang="en">Lozhkina N.G., Khasanova M.K., Tolmacheva A.A., Najdena E.A., Stafeeva E.A., Kozik V.A., Barbarich V.B., Kuimov A.D., Maksimov V.N., Voevoda M.I.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/3016">https://russjcardiol.elpub.ru/jour/article/view/3016</self-uri><abstract><sec><title>Цель</title><p>Цель. Выявить факторы отдаленного неблагоприятного прогноза больных, перенесших острый коронарный синдром (ОКС), в результате пятилетнего наблюдения.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование были включено 280 пациентов с ОКС, госпитализированных в 1 кардиологическое отделение ГБУЗ ГКБ № 1 города Новосибирска в 2010-2011гг. Состав исследуемой когорты больных: 145 пациентов с острым коронарным синдромом с подъемом сегмента ST (ОКСпST) (107 мужчин и 38 женщин), 135 пациентов с острым коронарным синдромом без подъема сегмента ST (ОКСбпST) (93 мужчины и 43 женщины). Средний возраст мужчин составил 56,3±5,2, женщин 52,1±5,3 лет. Для постановки диагноза ОКС использовались критерии Европейского общества кардиологов (2015г, 2017г). В течение пяти лет со всеми пациентами, включенными в исследование, поддерживался контакт с помощью средств связи и ежегодных медицинских осмотров, на которые пациенты были приглашены в клинику. Осмотры включали в себя следующие клинико-инструментальные методы: клинический осмотр, электрокардиография, холтеровское мониторирование электрокардиограммы, эхокардиография, исследование липидного профиля, воспалительных цитокинов и молекулярно-генетических показателей. В ходе исследования составлена математическая модель прогнозирования пятилетних исходов ОКСпST и ОКСбпST.</p></sec><sec><title>Результаты</title><p>Результаты. Пятилетнее наблюдение позволило с помощью построенной математической модели определить не только место каждого фактора в сер-дечно-сосудистом прогнозе, но и оценить, как меняется роль данных прогностических маркеров со временем.</p></sec><sec><title>Заключение</title><p>Заключение. Использование математической модели прогнозирования отдаленных неблагоприятных исходов ОКС позволяет оценить значение конкретных факторов риска и предикторов, вносит весомый вклад в оптимизацию вторичной профилактики и персонифицированного подхода к лечению. Вместе с тем, влияние выявленных предикторов ослабевает пропорционально увеличению количества лет от сосудистой катастрофы. Таким образом, выявленные факторы риска оказывают максимальное влияние в первый год после ОКС, в последующие годы роль данных факторов уменьшается, что, вероятно, связано не сколько с важностью самих факторов, сколько с присоединением других факторов риска в общую картину заболевания пациентов. Тем не менее, использование данной модели необходимо для решения проблемы снижения сердечно-сосудистого риска.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To identify the factors of long-term adverse prognosis of patients with acute coronary syndrome as a result of five-year follow-up.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 280 patients with ACS hospitalized in the 1st cardiology Department of the Novosibirsk municipal CLINICAL hospital № 1 in 2010-2011. The study cohort included 145 patients with ACS (107 men and 38 women), 135 patients with ACS (93 men and 43 women). The average age of men was 56,3±5,2, women 52,1±5,3 years. The criteria of the European society of cardiology (2015, 2017) were used for the diagnosis of ACS. For five years, all patients included in the study were contacted through communication and annual medical examinations, to which patients were invited to the clinic. The examinations included the following clinical and instrumental examinations: clinical examination, electrocardiography, Holter monitoring of electrocardiogram, echocardiography, lipid profile, inflammatory cytokines and molecular genetic parameters. In the study, a mathematical model for predicting five-year outcomes Oxpt and Oxbt. </p></sec><sec><title>Results</title><p>Results. Five-year observation allowed using the constructed mathematical model to determine not only the place of each factor in the cardiovascular prognosis, but also to assess how the role of these prognostic markers changes over time. </p></sec><sec><title>Conclusion</title><p>Conclusion. The use of a mathematical model for predicting long-term adverse outcomes of ACS allows to assess the value of specific risk factors and predictors, respectively, makes a significant contribution to the optimization of secondary prevention and personalized approach to treatment. At the same time, the influence of the identified predictors weakens in proportion to the increase in the number of years from a vascular accident. Thus, the identified risk factors have the maximum impact in the first year after ACS, in subsequent years, the role of these factors is reduced, which is probably due not only to the importance of the factors themselves, but also to the addition of other risk factors to the overall picture of the disease of patients. Nevertheless, the use of this model is necessary to solve the problem of reducing cardiovascular risk.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>острый коронарный синдром</kwd><kwd>инфаркт миокарда</kwd><kwd>прогностические факторы</kwd><kwd>многофакторное прогнозирование</kwd><kwd>генетические маркеры</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute coronary syndrome</kwd><kwd>myocardial infarction</kwd><kwd>prognostic factors</kwd><kwd>multifactorial prediction</kwd><kwd>genetic markers</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Минздрав России</funding-statement><funding-statement xml:lang="en">The Ministry of Health of Russia</funding-statement></funding-group></article-meta></front><body><p>Aim. to identify the factors of long-term adverse prognosis of patients with acute coronary syndrome as a result of five-year follow-up.</p><p>Material and methods. The study included 280 patients with ACS hospitalized in the 1st cardiology Department of the Novosibirsk municipal CLINICAL hospital №1 in 2010-2011. The study cohort included 145 patients with ACS (107 men and 38 women), 135 patients with ACS (93 men and 43 women). The average age of men was 56.3±5.2, women 52.1±5.3 years.  The criteria of the European society of cardiology (2015, 2017) were used for the diagnosis of ACS. For five years, all patients included in the study were contacted through communication and annual medical examinations, to which patients were invited to the clinic. The examinations included the following clinical and instrumental examinations: clinical examination, electrocardiography, Holter monitoring of electrocardiogram, echocardiography, lipid profile, inflammatory cytokines and molecular genetic parameters. In the study, a mathematical model for predicting five-year outcomes Oxpt and Oxbt.</p><p>Results. Five-year observation allowed using the constructed mathematical model to determine not only the place of each factor in the cardiovascular prognosis, but also to assess how the role of these prognostic markers changes over time.</p><p>Conclusion. The use of a mathematical model for predicting long-term adverse outcomes of ACS allows to assess the value of specific risk factors and predictors, respectively, makes a significant contribution to the optimization of secondary prevention and personalized approach to treatment.  At the same time, the influence of the identified predictors weakens in proportion to the increase in the number of years from a vascular accident. Thus, the identified risk factors have the maximum impact in the first year after ACS, in subsequent years, the role of these factors is reduced, which is probably due not only to the importance of the factors themselves, but also to the addition of other risk factors to the overall picture of the disease of patients.  Nevertheless, the use of this model is necessary to solve the problem of reducing cardiovascular risk.</p><p>Key words: acute coronary syndrome; myocardial infarction; prognostic factors; multifactorial prediction; genetic markers.</p></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Marco R, Carlo PA, Jean-Philippe C, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2015;11:1-59.</mixed-citation><mixed-citation xml:lang="en">Marco R, Carlo PA, Jean-Philippe C, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2015;11:1-59.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kang JS, Goodman SG, Yan RT, et al. Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events (GRACE) and Canadian Registry of Acute Coronary Events (CANRACE)). Am J Cardiol. 2013;112(1):51-6.</mixed-citation><mixed-citation xml:lang="en">Kang JS, Goodman SG, Yan RT, et al. Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events (GRACE) and Canadian Registry of Acute Coronary Events (CANRACE)). Am J Cardiol. 2013;112(1):51-6.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014 Feb 21;4(2):e004425.</mixed-citation><mixed-citation xml:lang="en">Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014 Feb 21;4(2):e004425.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Li YQ, Liu N, Lu JH. Outcomes in patients with non-ST-elevation acute coronary syndrome randomly assigned to invasive versus conservative treatment strategies: a meta-analysis. Clinics (Sao Paulo). 2014;69(6):398-404.</mixed-citation><mixed-citation xml:lang="en">Li YQ, Liu N, Lu JH. Outcomes in patients with non-ST-elevation acute coronary syndrome randomly assigned to invasive versus conservative treatment strategies: a meta-analysis. Clinics (Sao Paulo). 2014;69(6):398-404.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ложкина Н. Г., Максимов В. Н., Рагино Ю. И. и др. Проблемы прогнозирования исходов острого коронарного синдрома. Современные проблемы науки и образования. 2013;4. URL: http://science-education.ru/ru/article/view?id=9952 (дата обращения: 23.10.2018).</mixed-citation><mixed-citation xml:lang="en">Lozhkina NG, Maksimov VN, Ragino YI, et al. Problems of outcomes prognosis of acute coronary syndrome. Modern problems of science and education 2013;4. (In Russ.) URL: http://science-education.ru/ru/article/view?id=9952 (дата обращения: 23.10.2018).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Рабочая группа ЕОК. Рекомендации ЕОК по ведению пациентов с острым инфарктом миокарда с подъемом сегмента ST 2017. Российский кардиологический журнал. 2018;23(5):103-58. doi:10.15829/1560-4071-2018-5-103-158.</mixed-citation><mixed-citation xml:lang="en">Collet J-P, Kristensen St. D, Aboyans V, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Russ J Cardiol. 2018;23(5):103-58. (In Russ.) doi:10.15829/1560-4071-2018-5-103-158.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli MF, Hoes AW, Agewall S, et al. Европейские рекомендации по профилактике сердечно-сосудистых заболеваний в клинической практике (пересмотр 2016). Российский кардиологический журнал. 2017;22(6):7-85. doi:10.15829/1560-4071-2017-6-7-85.</mixed-citation><mixed-citation xml:lang="en">Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Russ J Cardiol. 2017;22(6):7-85 (In Russ) doi:10.15829/1560-4071-2017-6-7-85.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Максимов В. Н., Орлов П. С., Иванова А.А. и др. Комплексный подход при оценке информативности в Российской популяции генетических маркеров, ассоциированных с инфарктом миокарда и его факторами риска. Российский кардиологический журнал. 2017;22(10):33-41. doi:10.15829/1560-4071-2017-10-33-41.</mixed-citation><mixed-citation xml:lang="en">Maksimov VN, Orlov PS, Ivanova АА, et al. Complex evaluation of the significance of populational genetic markers associated With myocardial infarction and risk factors. Russ J Cardiol. 2017;22(10):33-41. (In Russ.) doi:10.15829/1560-4071-2017-10-33-41.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ложкина Н. Г., Максимов В. Н., Орлов П. С., и др. Генетические маркеры неблагоприятных исходов острого коронарного синдрома. Российский кардиологический журнал. 2014;19(10):19-22. doi:10.15829/1560-4071-2014-10-19-22.</mixed-citation><mixed-citation xml:lang="en">Lozhkina NG, Maksimov VN, Orlov PS et al. Genetic markers of negative outcomes of the acute coronary syndrome. Russ J Cardiol. 2014;19(10):19-22. (In Russ.) doi:10.15829/1560-4071-2014-10-19-22.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ложкина Н. Г., Хасанова М.Х., Куимов А. Д., и др. Многофакторное прогнозирование отдаленных исходов у пациентов, перенесших острый коронарный синдром без стойкого подъема сегмента ST. Кардиология. 2017;57(8):28-33.</mixed-citation><mixed-citation xml:lang="en">Lozhkina NG, Khasanova MH, Kuimov AD, et al. Multifactorial Prognostication of Remote Outcomes in Patients With Non-ST Elevation Acute Coronary Syndrome. Kardiologiia. 2017;57(8):28-33. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ложкина Н. Г., Максимов В. Н., Рагино Ю. И. и др. Многофакторное прогнозирование отдаленных исходов острого коронарного синдрома со стойким подъемом сегмента ST. Российский кардиологический журнал. 2015;22(9):25-31. doi:10.15829/1560-4071-2015-09-25-31.</mixed-citation><mixed-citation xml:lang="en">Lozhkina NG, Maksimov VN, Ragino YuI, et al. Multifactor prediction of long-term outcomes of acute coronary syndrome with sustained ST segment elevation. Russ J Cardiol. 2015;20(9):25-31. (In Russ.) doi:10.15829/1560-4071-2015-09-25-31.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
